nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—Benzphetamine—obesity	0.152	1	CrCtD
Atomoxetine—Norepinephrine Uptake Inhibitors—Bupropion—obesity	0.143	0.529	CiPCiCtD
Atomoxetine—Norepinephrine Uptake Inhibitors—Sibutramine—obesity	0.128	0.471	CiPCiCtD
Atomoxetine—NPY1R—obesity	0.0747	0.605	CbGaD
Atomoxetine—attention deficit hyperactivity disorder—Bupropion—obesity	0.0657	0.5	CpDpCtD
Atomoxetine—attention deficit hyperactivity disorder—Methamphetamine—obesity	0.0657	0.5	CpDpCtD
Atomoxetine—HTR1B—obesity	0.0162	0.131	CbGaD
Atomoxetine—HTR2C—obesity	0.0132	0.107	CbGaD
Atomoxetine—SLC6A3—Diethylpropion—obesity	0.0125	0.0871	CbGbCtD
Atomoxetine—SLC6A4—obesity	0.011	0.0887	CbGaD
Atomoxetine—Ephedrine—Phenylpropanolamine—obesity	0.0105	0.0919	CrCrCtD
Atomoxetine—Pseudoephedrine—Phenylpropanolamine—obesity	0.0105	0.0919	CrCrCtD
Atomoxetine—SLC6A3—Phendimetrazine—obesity	0.0095	0.066	CbGbCtD
Atomoxetine—SLC6A3—Sibutramine—obesity	0.0095	0.066	CbGbCtD
Atomoxetine—SLC6A2—Diethylpropion—obesity	0.00917	0.0638	CbGbCtD
Atomoxetine—Ephedrine—Phentermine—obesity	0.00893	0.0781	CrCrCtD
Atomoxetine—Pseudoephedrine—Phentermine—obesity	0.00893	0.0781	CrCrCtD
Atomoxetine—HTR2A—obesity	0.00842	0.0682	CbGaD
Atomoxetine—SLC6A4—Sibutramine—obesity	0.00831	0.0578	CbGbCtD
Atomoxetine—Pseudoephedrine—Methamphetamine—obesity	0.00796	0.0696	CrCrCtD
Atomoxetine—Ephedrine—Methamphetamine—obesity	0.00796	0.0696	CrCrCtD
Atomoxetine—SLC6A3—Phentermine—obesity	0.0072	0.05	CbGbCtD
Atomoxetine—SLC6A3—Benzphetamine—obesity	0.0072	0.05	CbGbCtD
Atomoxetine—SLC6A2—Phendimetrazine—obesity	0.00695	0.0483	CbGbCtD
Atomoxetine—SLC6A2—Sibutramine—obesity	0.00695	0.0483	CbGbCtD
Atomoxetine—SLC6A3—Phenylpropanolamine—obesity	0.00687	0.0477	CbGbCtD
Atomoxetine—SLC6A4—Phentermine—obesity	0.0063	0.0438	CbGbCtD
Atomoxetine—SLC6A3—Bupropion—obesity	0.00612	0.0425	CbGbCtD
Atomoxetine—SLC6A3—Methamphetamine—obesity	0.00575	0.04	CbGbCtD
Atomoxetine—Propafenone—Benzphetamine—obesity	0.00528	0.0462	CrCrCtD
Atomoxetine—SLC6A2—Benzphetamine—obesity	0.00527	0.0366	CbGbCtD
Atomoxetine—SLC6A2—Phentermine—obesity	0.00527	0.0366	CbGbCtD
Atomoxetine—Phenprocoumon—Benzphetamine—obesity	0.00508	0.0444	CrCrCtD
Atomoxetine—SLC6A4—Methamphetamine—obesity	0.00503	0.035	CbGbCtD
Atomoxetine—SLC6A2—Phenylpropanolamine—obesity	0.00502	0.0349	CbGbCtD
Atomoxetine—Benzatropine—Benzphetamine—obesity	0.00489	0.0428	CrCrCtD
Atomoxetine—Eprazinone—Benzphetamine—obesity	0.00456	0.0399	CrCrCtD
Atomoxetine—SLC6A2—Bupropion—obesity	0.00448	0.0311	CbGbCtD
Atomoxetine—SLC6A2—Methamphetamine—obesity	0.00421	0.0293	CbGbCtD
Atomoxetine—Doxylamine—Benzphetamine—obesity	0.00382	0.0334	CrCrCtD
Atomoxetine—Phenoxybenzamine—Benzphetamine—obesity	0.00362	0.0317	CrCrCtD
Atomoxetine—Diphenylpyraline—Benzphetamine—obesity	0.00345	0.0302	CrCrCtD
Atomoxetine—Modafinil—Benzphetamine—obesity	0.00337	0.0295	CrCrCtD
Atomoxetine—Bromodiphenhydramine—Benzphetamine—obesity	0.00323	0.0282	CrCrCtD
Atomoxetine—Benzphetamine—Methamphetamine—obesity	0.0032	0.028	CrCrCtD
Atomoxetine—Pheniramine—Benzphetamine—obesity	0.00316	0.0276	CrCrCtD
Atomoxetine—Cyclizine—Benzphetamine—obesity	0.00309	0.0271	CrCrCtD
Atomoxetine—Methadone—Benzphetamine—obesity	0.00303	0.0265	CrCrCtD
Atomoxetine—Clofedanol—Benzphetamine—obesity	0.00262	0.0229	CrCrCtD
Atomoxetine—Orphenadrine—Benzphetamine—obesity	0.00254	0.0222	CrCrCtD
Atomoxetine—Benzyl Benzoate—Benzphetamine—obesity	0.00235	0.0206	CrCrCtD
Atomoxetine—Diphenhydramine—Benzphetamine—obesity	0.00225	0.0197	CrCrCtD
Atomoxetine—CYP2D6—Phentermine—obesity	0.00158	0.011	CbGbCtD
Atomoxetine—CYP2D6—Bupropion—obesity	0.00134	0.00934	CbGbCtD
Atomoxetine—CYP3A4—Sibutramine—obesity	0.00132	0.00921	CbGbCtD
Atomoxetine—CYP2C19—Cimetidine—obesity	0.0013	0.00901	CbGbCtD
Atomoxetine—CYP2D6—Methamphetamine—obesity	0.00126	0.00878	CbGbCtD
Atomoxetine—CYP3A4—Benzphetamine—obesity	0.001	0.00698	CbGbCtD
Atomoxetine—CYP2D6—Cimetidine—obesity	0.000986	0.00685	CbGbCtD
Atomoxetine—CYP3A4—Bupropion—obesity	0.000854	0.00594	CbGbCtD
Atomoxetine—CYP2C19—Topiramate—obesity	0.000849	0.0059	CbGbCtD
Atomoxetine—CYP3A4—Orlistat—obesity	0.000696	0.00484	CbGbCtD
Atomoxetine—SLC6A2—sympathetic nervous system—obesity	0.000692	0.115	CbGeAlD
Atomoxetine—CYP3A4—Cimetidine—obesity	0.000627	0.00436	CbGbCtD
Atomoxetine—SLC6A2—autonomic nervous system—obesity	0.000465	0.0772	CbGeAlD
Atomoxetine—HTR2A—sympathetic nervous system—obesity	0.000416	0.0691	CbGeAlD
Atomoxetine—CYP3A4—Topiramate—obesity	0.00041	0.00285	CbGbCtD
Atomoxetine—HTR2A—vagus nerve—obesity	0.000403	0.0669	CbGeAlD
Atomoxetine—NPY1R—adrenal cortex—obesity	0.000296	0.0491	CbGeAlD
Atomoxetine—HTR2A—autonomic nervous system—obesity	0.00028	0.0464	CbGeAlD
Atomoxetine—SLC6A3—hindbrain—obesity	0.000243	0.0403	CbGeAlD
Atomoxetine—NPY1R—pituitary gland—obesity	0.000239	0.0397	CbGeAlD
Atomoxetine—NPY1R—adipose tissue—obesity	0.000238	0.0395	CbGeAlD
Atomoxetine—SLC6A4—hindbrain—obesity	0.000223	0.037	CbGeAlD
Atomoxetine—NPY1R—adrenal gland—obesity	0.000214	0.0355	CbGeAlD
Atomoxetine—NPY1R—endocrine gland—obesity	0.000185	0.0308	CbGeAlD
Atomoxetine—NPY1R—liver—obesity	0.000167	0.0277	CbGeAlD
Atomoxetine—SLC6A3—respiratory system—obesity	0.000148	0.0246	CbGeAlD
Atomoxetine—Duloxetine—NPY1R—obesity	0.000137	0.169	CrCbGaD
Atomoxetine—SLC6A4—respiratory system—obesity	0.000136	0.0226	CbGeAlD
Atomoxetine—SLC6A2—respiratory system—obesity	0.00012	0.0199	CbGeAlD
Atomoxetine—HTR2A—hindbrain—obesity	0.000118	0.0196	CbGeAlD
Atomoxetine—HTR1B—cardiovascular system—obesity	0.000115	0.019	CbGeAlD
Atomoxetine—HTR1D—cardiovascular system—obesity	0.000111	0.0184	CbGeAlD
Atomoxetine—CYP2D6—hindbrain—obesity	0.000107	0.0178	CbGeAlD
Atomoxetine—SLC6A4—digestive system—obesity	8.65e-05	0.0143	CbGeAlD
Atomoxetine—HTR1B—endocrine gland—obesity	7.86e-05	0.013	CbGeAlD
Atomoxetine—SLC6A2—adrenal gland—obesity	7.25e-05	0.012	CbGeAlD
Atomoxetine—HTR2A—respiratory system—obesity	7.2e-05	0.0119	CbGeAlD
Atomoxetine—CYP2C19—digestive system—obesity	7.17e-05	0.0119	CbGeAlD
Atomoxetine—SLC6A4—endocrine gland—obesity	7.15e-05	0.0119	CbGeAlD
Atomoxetine—SLC6A2—endocrine gland—obesity	6.29e-05	0.0104	CbGeAlD
Atomoxetine—CYP2C19—endocrine gland—obesity	5.92e-05	0.00982	CbGeAlD
Atomoxetine—HTR2A—cardiovascular system—obesity	5.51e-05	0.00915	CbGeAlD
Atomoxetine—CYP2C19—liver—obesity	5.34e-05	0.00886	CbGeAlD
Atomoxetine—HTR2A—pituitary gland—obesity	4.88e-05	0.0081	CbGeAlD
Atomoxetine—HTR2A—digestive system—obesity	4.58e-05	0.00759	CbGeAlD
Atomoxetine—HTR2A—adrenal gland—obesity	4.36e-05	0.00723	CbGeAlD
Atomoxetine—CYP3A4—digestive system—obesity	4.24e-05	0.00703	CbGeAlD
Atomoxetine—CYP2D6—digestive system—obesity	4.17e-05	0.00692	CbGeAlD
Atomoxetine—HTR2A—endocrine gland—obesity	3.78e-05	0.00627	CbGeAlD
Atomoxetine—CYP3A4—endocrine gland—obesity	3.5e-05	0.00581	CbGeAlD
Atomoxetine—CYP2D6—endocrine gland—obesity	3.44e-05	0.00572	CbGeAlD
Atomoxetine—HTR2A—liver—obesity	3.41e-05	0.00566	CbGeAlD
Atomoxetine—CYP3A4—liver—obesity	3.16e-05	0.00524	CbGeAlD
Atomoxetine—Reboxetine—HTR2C—obesity	3.16e-05	0.0389	CrCbGaD
Atomoxetine—CYP2D6—liver—obesity	3.11e-05	0.00515	CbGeAlD
Atomoxetine—Dysgeusia—Orlistat—obesity	2.94e-05	0.000863	CcSEcCtD
Atomoxetine—Dermatitis—Diethylpropion—obesity	2.93e-05	0.000863	CcSEcCtD
Atomoxetine—Dizziness—Cimetidine—obesity	2.93e-05	0.000862	CcSEcCtD
Atomoxetine—Headache—Diethylpropion—obesity	2.92e-05	0.000858	CcSEcCtD
Atomoxetine—Malnutrition—Sibutramine—obesity	2.9e-05	0.000853	CcSEcCtD
Atomoxetine—Back pain—Orlistat—obesity	2.9e-05	0.000853	CcSEcCtD
Atomoxetine—Propranolol—ADRB3—obesity	2.9e-05	0.0357	CrCbGaD
Atomoxetine—Hallucination—Bupropion—obesity	2.89e-05	0.00085	CcSEcCtD
Atomoxetine—Hypoaesthesia—Bupropion—obesity	2.89e-05	0.00085	CcSEcCtD
Atomoxetine—Libido decreased—Topiramate—obesity	2.89e-05	0.000849	CcSEcCtD
Atomoxetine—Muscle spasms—Orlistat—obesity	2.88e-05	0.000848	CcSEcCtD
Atomoxetine—Urinary tract disorder—Bupropion—obesity	2.87e-05	0.000844	CcSEcCtD
Atomoxetine—Hot flush—Topiramate—obesity	2.86e-05	0.000841	CcSEcCtD
Atomoxetine—Flatulence—Sibutramine—obesity	2.86e-05	0.000841	CcSEcCtD
Atomoxetine—Urethral disorder—Bupropion—obesity	2.85e-05	0.000838	CcSEcCtD
Atomoxetine—Tension—Sibutramine—obesity	2.85e-05	0.000837	CcSEcCtD
Atomoxetine—Dysgeusia—Sibutramine—obesity	2.84e-05	0.000836	CcSEcCtD
Atomoxetine—Menopausal symptoms—Topiramate—obesity	2.84e-05	0.000834	CcSEcCtD
Atomoxetine—Vision blurred—Orlistat—obesity	2.83e-05	0.000831	CcSEcCtD
Atomoxetine—Nervousness—Sibutramine—obesity	2.82e-05	0.000829	CcSEcCtD
Atomoxetine—Vomiting—Cimetidine—obesity	2.82e-05	0.000829	CcSEcCtD
Atomoxetine—Thirst—Topiramate—obesity	2.81e-05	0.000827	CcSEcCtD
Atomoxetine—Back pain—Sibutramine—obesity	2.81e-05	0.000825	CcSEcCtD
Atomoxetine—Rash—Cimetidine—obesity	2.79e-05	0.000822	CcSEcCtD
Atomoxetine—Dermatitis—Cimetidine—obesity	2.79e-05	0.000821	CcSEcCtD
Atomoxetine—Muscle spasms—Sibutramine—obesity	2.79e-05	0.00082	CcSEcCtD
Atomoxetine—Headache—Cimetidine—obesity	2.78e-05	0.000817	CcSEcCtD
Atomoxetine—Nausea—Diethylpropion—obesity	2.77e-05	0.000814	CcSEcCtD
Atomoxetine—Vision blurred—Sibutramine—obesity	2.73e-05	0.000804	CcSEcCtD
Atomoxetine—Lethargy—Topiramate—obesity	2.73e-05	0.000803	CcSEcCtD
Atomoxetine—Tremor—Sibutramine—obesity	2.72e-05	0.000799	CcSEcCtD
Atomoxetine—Cardiac disorder—Bupropion—obesity	2.7e-05	0.000793	CcSEcCtD
Atomoxetine—Flushing—Bupropion—obesity	2.7e-05	0.000793	CcSEcCtD
Atomoxetine—Vertigo—Orlistat—obesity	2.69e-05	0.000792	CcSEcCtD
Atomoxetine—Agitation—Sibutramine—obesity	2.67e-05	0.000784	CcSEcCtD
Atomoxetine—Disturbance in sexual arousal—Topiramate—obesity	2.66e-05	0.000781	CcSEcCtD
Atomoxetine—Palpitations—Orlistat—obesity	2.65e-05	0.000779	CcSEcCtD
Atomoxetine—Angiopathy—Bupropion—obesity	2.64e-05	0.000775	CcSEcCtD
Atomoxetine—Affect lability—Topiramate—obesity	2.63e-05	0.000775	CcSEcCtD
Atomoxetine—Nausea—Cimetidine—obesity	2.63e-05	0.000774	CcSEcCtD
Atomoxetine—Mediastinal disorder—Bupropion—obesity	2.62e-05	0.00077	CcSEcCtD
Atomoxetine—Cough—Orlistat—obesity	2.62e-05	0.000769	CcSEcCtD
Atomoxetine—Reboxetine—SLC6A4—obesity	2.61e-05	0.0322	CrCbGaD
Atomoxetine—Psychotic disorder—Topiramate—obesity	2.61e-05	0.000769	CcSEcCtD
Atomoxetine—Chills—Bupropion—obesity	2.61e-05	0.000767	CcSEcCtD
Atomoxetine—Vertigo—Sibutramine—obesity	2.61e-05	0.000767	CcSEcCtD
Atomoxetine—Syncope—Sibutramine—obesity	2.6e-05	0.000765	CcSEcCtD
Atomoxetine—Convulsion—Orlistat—obesity	2.6e-05	0.000764	CcSEcCtD
Atomoxetine—Palpitations—Sibutramine—obesity	2.56e-05	0.000754	CcSEcCtD
Atomoxetine—Irritability—Topiramate—obesity	2.55e-05	0.000751	CcSEcCtD
Atomoxetine—Myalgia—Orlistat—obesity	2.55e-05	0.000751	CcSEcCtD
Atomoxetine—Chest pain—Orlistat—obesity	2.55e-05	0.000751	CcSEcCtD
Atomoxetine—Loss of consciousness—Sibutramine—obesity	2.55e-05	0.00075	CcSEcCtD
Atomoxetine—Mental disorder—Bupropion—obesity	2.55e-05	0.000749	CcSEcCtD
Atomoxetine—Urinary retention—Topiramate—obesity	2.55e-05	0.000748	CcSEcCtD
Atomoxetine—Anxiety—Orlistat—obesity	2.54e-05	0.000748	CcSEcCtD
Atomoxetine—Mood swings—Topiramate—obesity	2.54e-05	0.000746	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	2.54e-05	0.000745	CcSEcCtD
Atomoxetine—Cough—Sibutramine—obesity	2.53e-05	0.000745	CcSEcCtD
Atomoxetine—Malnutrition—Bupropion—obesity	2.53e-05	0.000744	CcSEcCtD
Atomoxetine—Convulsion—Sibutramine—obesity	2.51e-05	0.000739	CcSEcCtD
Atomoxetine—Dry mouth—Orlistat—obesity	2.5e-05	0.000734	CcSEcCtD
Atomoxetine—Flatulence—Bupropion—obesity	2.49e-05	0.000733	CcSEcCtD
Atomoxetine—Tension—Bupropion—obesity	2.48e-05	0.00073	CcSEcCtD
Atomoxetine—Dysgeusia—Bupropion—obesity	2.48e-05	0.000728	CcSEcCtD
Atomoxetine—Arthralgia—Sibutramine—obesity	2.47e-05	0.000726	CcSEcCtD
Atomoxetine—Chest pain—Sibutramine—obesity	2.47e-05	0.000726	CcSEcCtD
Atomoxetine—Myalgia—Sibutramine—obesity	2.47e-05	0.000726	CcSEcCtD
Atomoxetine—Anxiety—Sibutramine—obesity	2.46e-05	0.000724	CcSEcCtD
Atomoxetine—Nervousness—Bupropion—obesity	2.46e-05	0.000722	CcSEcCtD
Atomoxetine—Back pain—Bupropion—obesity	2.45e-05	0.00072	CcSEcCtD
Atomoxetine—Abdominal pain upper—Topiramate—obesity	2.44e-05	0.000719	CcSEcCtD
Atomoxetine—Muscle spasms—Bupropion—obesity	2.43e-05	0.000715	CcSEcCtD
Atomoxetine—Infection—Orlistat—obesity	2.43e-05	0.000715	CcSEcCtD
Atomoxetine—Duloxetine—HTR2C—obesity	2.43e-05	0.0299	CrCbGaD
Atomoxetine—Breast disorder—Topiramate—obesity	2.42e-05	0.000711	CcSEcCtD
Atomoxetine—Dry mouth—Sibutramine—obesity	2.42e-05	0.00071	CcSEcCtD
Atomoxetine—Ephedrine—BCHE—obesity	2.41e-05	0.0297	CrCbGaD
Atomoxetine—Protriptyline—SLC6A4—obesity	2.4e-05	0.0296	CrCbGaD
Atomoxetine—Nervous system disorder—Orlistat—obesity	2.4e-05	0.000706	CcSEcCtD
Atomoxetine—Nasopharyngitis—Topiramate—obesity	2.39e-05	0.000704	CcSEcCtD
Atomoxetine—Vision blurred—Bupropion—obesity	2.38e-05	0.000701	CcSEcCtD
Atomoxetine—Skin disorder—Orlistat—obesity	2.38e-05	0.000699	CcSEcCtD
Atomoxetine—Tremor—Bupropion—obesity	2.37e-05	0.000697	CcSEcCtD
Atomoxetine—Hyperhidrosis—Orlistat—obesity	2.37e-05	0.000696	CcSEcCtD
Atomoxetine—Infection—Sibutramine—obesity	2.35e-05	0.000692	CcSEcCtD
Atomoxetine—Shock—Sibutramine—obesity	2.33e-05	0.000685	CcSEcCtD
Atomoxetine—Agitation—Bupropion—obesity	2.32e-05	0.000684	CcSEcCtD
Atomoxetine—Tachycardia—Sibutramine—obesity	2.31e-05	0.00068	CcSEcCtD
Atomoxetine—Skin disorder—Sibutramine—obesity	2.3e-05	0.000676	CcSEcCtD
Atomoxetine—Hyperhidrosis—Sibutramine—obesity	2.29e-05	0.000673	CcSEcCtD
Atomoxetine—Vertigo—Bupropion—obesity	2.27e-05	0.000668	CcSEcCtD
Atomoxetine—Syncope—Bupropion—obesity	2.27e-05	0.000667	CcSEcCtD
Atomoxetine—Anorexia—Sibutramine—obesity	2.26e-05	0.000664	CcSEcCtD
Atomoxetine—Sweating increased—Topiramate—obesity	2.25e-05	0.000663	CcSEcCtD
Atomoxetine—Palpitations—Bupropion—obesity	2.24e-05	0.000657	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Orlistat—obesity	2.23e-05	0.000656	CcSEcCtD
Atomoxetine—Loss of consciousness—Bupropion—obesity	2.22e-05	0.000654	CcSEcCtD
Atomoxetine—Abdominal discomfort—Topiramate—obesity	2.22e-05	0.000652	CcSEcCtD
Atomoxetine—Insomnia—Orlistat—obesity	2.21e-05	0.000651	CcSEcCtD
Atomoxetine—Cough—Bupropion—obesity	2.21e-05	0.000649	CcSEcCtD
Atomoxetine—Paraesthesia—Orlistat—obesity	2.2e-05	0.000646	CcSEcCtD
Atomoxetine—Convulsion—Bupropion—obesity	2.19e-05	0.000645	CcSEcCtD
Atomoxetine—Dysuria—Topiramate—obesity	2.16e-05	0.000636	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Sibutramine—obesity	2.16e-05	0.000634	CcSEcCtD
Atomoxetine—Dyspepsia—Orlistat—obesity	2.15e-05	0.000633	CcSEcCtD
Atomoxetine—Myalgia—Bupropion—obesity	2.15e-05	0.000633	CcSEcCtD
Atomoxetine—Arthralgia—Bupropion—obesity	2.15e-05	0.000633	CcSEcCtD
Atomoxetine—Chest pain—Bupropion—obesity	2.15e-05	0.000633	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Topiramate—obesity	2.15e-05	0.000632	CcSEcCtD
Atomoxetine—Anxiety—Bupropion—obesity	2.15e-05	0.000631	CcSEcCtD
Atomoxetine—Insomnia—Sibutramine—obesity	2.14e-05	0.00063	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2.14e-05	0.000629	CcSEcCtD
Atomoxetine—Pollakiuria—Topiramate—obesity	2.14e-05	0.000628	CcSEcCtD
Atomoxetine—Erectile dysfunction—Topiramate—obesity	2.13e-05	0.000626	CcSEcCtD
Atomoxetine—Decreased appetite—Orlistat—obesity	2.13e-05	0.000626	CcSEcCtD
Atomoxetine—Paraesthesia—Sibutramine—obesity	2.13e-05	0.000625	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Orlistat—obesity	2.11e-05	0.000621	CcSEcCtD
Atomoxetine—Fatigue—Orlistat—obesity	2.11e-05	0.00062	CcSEcCtD
Atomoxetine—Dry mouth—Bupropion—obesity	2.11e-05	0.000619	CcSEcCtD
Atomoxetine—Somnolence—Sibutramine—obesity	2.11e-05	0.000619	CcSEcCtD
Atomoxetine—Weight decreased—Topiramate—obesity	2.09e-05	0.000615	CcSEcCtD
Atomoxetine—Pain—Orlistat—obesity	2.09e-05	0.000615	CcSEcCtD
Atomoxetine—Dyspepsia—Sibutramine—obesity	2.08e-05	0.000613	CcSEcCtD
Atomoxetine—Ephedrine—ADRB2—obesity	2.07e-05	0.0255	CrCbGaD
Atomoxetine—Infestation NOS—Topiramate—obesity	2.06e-05	0.000606	CcSEcCtD
Atomoxetine—Infestation—Topiramate—obesity	2.06e-05	0.000606	CcSEcCtD
Atomoxetine—Decreased appetite—Sibutramine—obesity	2.06e-05	0.000605	CcSEcCtD
Atomoxetine—Depression—Topiramate—obesity	2.06e-05	0.000605	CcSEcCtD
Atomoxetine—Infection—Bupropion—obesity	2.05e-05	0.000603	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Sibutramine—obesity	2.04e-05	0.000601	CcSEcCtD
Atomoxetine—Shock—Bupropion—obesity	2.03e-05	0.000597	CcSEcCtD
Atomoxetine—Pain—Sibutramine—obesity	2.03e-05	0.000596	CcSEcCtD
Atomoxetine—Constipation—Sibutramine—obesity	2.03e-05	0.000596	CcSEcCtD
Atomoxetine—Nervous system disorder—Bupropion—obesity	2.02e-05	0.000595	CcSEcCtD
Atomoxetine—Feeling abnormal—Orlistat—obesity	2.02e-05	0.000593	CcSEcCtD
Atomoxetine—Tachycardia—Bupropion—obesity	2.02e-05	0.000593	CcSEcCtD
Atomoxetine—Duloxetine—SLC6A4—obesity	2.01e-05	0.0248	CrCbGaD
Atomoxetine—Skin disorder—Bupropion—obesity	2.01e-05	0.00059	CcSEcCtD
Atomoxetine—Conjunctivitis—Topiramate—obesity	2e-05	0.000589	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Orlistat—obesity	2e-05	0.000588	CcSEcCtD
Atomoxetine—Hyperhidrosis—Bupropion—obesity	2e-05	0.000587	CcSEcCtD
Atomoxetine—Fluoxetine—HTR2C—obesity	1.98e-05	0.0244	CrCbGaD
Atomoxetine—Anorexia—Bupropion—obesity	1.97e-05	0.000579	CcSEcCtD
Atomoxetine—Feeling abnormal—Sibutramine—obesity	1.95e-05	0.000574	CcSEcCtD
Atomoxetine—Urticaria—Orlistat—obesity	1.94e-05	0.000572	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Sibutramine—obesity	1.94e-05	0.000569	CcSEcCtD
Atomoxetine—Sinusitis—Topiramate—obesity	1.94e-05	0.000569	CcSEcCtD
Atomoxetine—Body temperature increased—Orlistat—obesity	1.93e-05	0.000569	CcSEcCtD
Atomoxetine—Abdominal pain—Orlistat—obesity	1.93e-05	0.000569	CcSEcCtD
Atomoxetine—Propafenone—ADRB1—obesity	1.91e-05	0.0236	CrCbGaD
Atomoxetine—Urticaria—Sibutramine—obesity	1.88e-05	0.000553	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Bupropion—obesity	1.88e-05	0.000553	CcSEcCtD
Atomoxetine—Body temperature increased—Sibutramine—obesity	1.87e-05	0.000551	CcSEcCtD
Atomoxetine—Abdominal pain—Sibutramine—obesity	1.87e-05	0.000551	CcSEcCtD
Atomoxetine—Insomnia—Bupropion—obesity	1.87e-05	0.000549	CcSEcCtD
Atomoxetine—Pseudoephedrine—ADRB1—obesity	1.86e-05	0.023	CrCbGaD
Atomoxetine—Paraesthesia—Bupropion—obesity	1.85e-05	0.000545	CcSEcCtD
Atomoxetine—Maprotiline—HTR2C—obesity	1.85e-05	0.0228	CrCbGaD
Atomoxetine—Hallucination—Topiramate—obesity	1.84e-05	0.000542	CcSEcCtD
Atomoxetine—Hypoaesthesia—Topiramate—obesity	1.84e-05	0.000542	CcSEcCtD
Atomoxetine—Somnolence—Bupropion—obesity	1.84e-05	0.00054	CcSEcCtD
Atomoxetine—Urinary tract disorder—Topiramate—obesity	1.83e-05	0.000538	CcSEcCtD
Atomoxetine—Dyspepsia—Bupropion—obesity	1.82e-05	0.000534	CcSEcCtD
Atomoxetine—Urethral disorder—Topiramate—obesity	1.82e-05	0.000534	CcSEcCtD
Atomoxetine—Decreased appetite—Bupropion—obesity	1.79e-05	0.000528	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Bupropion—obesity	1.78e-05	0.000524	CcSEcCtD
Atomoxetine—Fatigue—Bupropion—obesity	1.78e-05	0.000523	CcSEcCtD
Atomoxetine—Pseudoephedrine—TNF—obesity	1.77e-05	0.0218	CrCbGaD
Atomoxetine—Pain—Bupropion—obesity	1.77e-05	0.000519	CcSEcCtD
Atomoxetine—Constipation—Bupropion—obesity	1.77e-05	0.000519	CcSEcCtD
Atomoxetine—Asthenia—Orlistat—obesity	1.76e-05	0.000516	CcSEcCtD
Atomoxetine—Phenoxybenzamine—SLC22A1—obesity	1.75e-05	0.0216	CrCbGaD
Atomoxetine—Pruritus—Orlistat—obesity	1.73e-05	0.000509	CcSEcCtD
Atomoxetine—Flushing—Topiramate—obesity	1.72e-05	0.000505	CcSEcCtD
Atomoxetine—Cardiac disorder—Topiramate—obesity	1.72e-05	0.000505	CcSEcCtD
Atomoxetine—Feeling abnormal—Bupropion—obesity	1.7e-05	0.0005	CcSEcCtD
Atomoxetine—Asthenia—Sibutramine—obesity	1.7e-05	0.0005	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Bupropion—obesity	1.69e-05	0.000496	CcSEcCtD
Atomoxetine—Angiopathy—Topiramate—obesity	1.68e-05	0.000494	CcSEcCtD
Atomoxetine—Pruritus—Sibutramine—obesity	1.68e-05	0.000493	CcSEcCtD
Atomoxetine—Diarrhoea—Orlistat—obesity	1.67e-05	0.000492	CcSEcCtD
Atomoxetine—Mediastinal disorder—Topiramate—obesity	1.67e-05	0.000491	CcSEcCtD
Atomoxetine—Chills—Topiramate—obesity	1.66e-05	0.000488	CcSEcCtD
Atomoxetine—Urticaria—Bupropion—obesity	1.64e-05	0.000482	CcSEcCtD
Atomoxetine—Fluoxetine—SLC6A4—obesity	1.64e-05	0.0202	CrCbGaD
Atomoxetine—Abdominal pain—Bupropion—obesity	1.63e-05	0.00048	CcSEcCtD
Atomoxetine—Body temperature increased—Bupropion—obesity	1.63e-05	0.00048	CcSEcCtD
Atomoxetine—Mental disorder—Topiramate—obesity	1.62e-05	0.000477	CcSEcCtD
Atomoxetine—Diarrhoea—Sibutramine—obesity	1.62e-05	0.000476	CcSEcCtD
Atomoxetine—Dizziness—Orlistat—obesity	1.62e-05	0.000476	CcSEcCtD
Atomoxetine—Malnutrition—Topiramate—obesity	1.61e-05	0.000474	CcSEcCtD
Atomoxetine—Flatulence—Topiramate—obesity	1.59e-05	0.000467	CcSEcCtD
Atomoxetine—Tension—Topiramate—obesity	1.58e-05	0.000465	CcSEcCtD
Atomoxetine—Dysgeusia—Topiramate—obesity	1.58e-05	0.000464	CcSEcCtD
Atomoxetine—Pseudoephedrine—ADRB2—obesity	1.57e-05	0.0193	CrCbGaD
Atomoxetine—Dizziness—Sibutramine—obesity	1.57e-05	0.000461	CcSEcCtD
Atomoxetine—Nervousness—Topiramate—obesity	1.57e-05	0.00046	CcSEcCtD
Atomoxetine—Back pain—Topiramate—obesity	1.56e-05	0.000458	CcSEcCtD
Atomoxetine—Vomiting—Orlistat—obesity	1.56e-05	0.000458	CcSEcCtD
Atomoxetine—Muscle spasms—Topiramate—obesity	1.55e-05	0.000456	CcSEcCtD
Atomoxetine—Duloxetine—HTR2A—obesity	1.54e-05	0.0191	CrCbGaD
Atomoxetine—Rash—Orlistat—obesity	1.54e-05	0.000454	CcSEcCtD
Atomoxetine—Dermatitis—Orlistat—obesity	1.54e-05	0.000453	CcSEcCtD
Atomoxetine—Headache—Orlistat—obesity	1.53e-05	0.000451	CcSEcCtD
Atomoxetine—Maprotiline—DRD2—obesity	1.52e-05	0.0188	CrCbGaD
Atomoxetine—Vision blurred—Topiramate—obesity	1.52e-05	0.000447	CcSEcCtD
Atomoxetine—Tremor—Topiramate—obesity	1.51e-05	0.000444	CcSEcCtD
Atomoxetine—Vomiting—Sibutramine—obesity	1.51e-05	0.000443	CcSEcCtD
Atomoxetine—Rash—Sibutramine—obesity	1.49e-05	0.000439	CcSEcCtD
Atomoxetine—Dermatitis—Sibutramine—obesity	1.49e-05	0.000439	CcSEcCtD
Atomoxetine—Headache—Sibutramine—obesity	1.48e-05	0.000436	CcSEcCtD
Atomoxetine—Asthenia—Bupropion—obesity	1.48e-05	0.000436	CcSEcCtD
Atomoxetine—Agitation—Topiramate—obesity	1.48e-05	0.000436	CcSEcCtD
Atomoxetine—Propranolol—HTR1B—obesity	1.48e-05	0.0183	CrCbGaD
Atomoxetine—Diphenhydramine—SLC22A1—obesity	1.47e-05	0.0181	CrCbGaD
Atomoxetine—Pruritus—Bupropion—obesity	1.46e-05	0.00043	CcSEcCtD
Atomoxetine—Nausea—Orlistat—obesity	1.45e-05	0.000427	CcSEcCtD
Atomoxetine—Vertigo—Topiramate—obesity	1.45e-05	0.000426	CcSEcCtD
Atomoxetine—Syncope—Topiramate—obesity	1.45e-05	0.000425	CcSEcCtD
Atomoxetine—Palpitations—Topiramate—obesity	1.42e-05	0.000419	CcSEcCtD
Atomoxetine—Pseudoephedrine—SLC6A4—obesity	1.42e-05	0.0176	CrCbGaD
Atomoxetine—Loss of consciousness—Topiramate—obesity	1.42e-05	0.000417	CcSEcCtD
Atomoxetine—Diarrhoea—Bupropion—obesity	1.41e-05	0.000415	CcSEcCtD
Atomoxetine—Nausea—Sibutramine—obesity	1.41e-05	0.000414	CcSEcCtD
Atomoxetine—Cough—Topiramate—obesity	1.41e-05	0.000414	CcSEcCtD
Atomoxetine—Convulsion—Topiramate—obesity	1.4e-05	0.000411	CcSEcCtD
Atomoxetine—Chest pain—Topiramate—obesity	1.37e-05	0.000403	CcSEcCtD
Atomoxetine—Myalgia—Topiramate—obesity	1.37e-05	0.000403	CcSEcCtD
Atomoxetine—Arthralgia—Topiramate—obesity	1.37e-05	0.000403	CcSEcCtD
Atomoxetine—Anxiety—Topiramate—obesity	1.37e-05	0.000402	CcSEcCtD
Atomoxetine—Dizziness—Bupropion—obesity	1.37e-05	0.000401	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.36e-05	0.000401	CcSEcCtD
Atomoxetine—Dry mouth—Topiramate—obesity	1.34e-05	0.000395	CcSEcCtD
Atomoxetine—Vomiting—Bupropion—obesity	1.31e-05	0.000386	CcSEcCtD
Atomoxetine—Propranolol—ADRB1—obesity	1.31e-05	0.0162	CrCbGaD
Atomoxetine—Desipramine—SLC22A1—obesity	1.31e-05	0.0161	CrCbGaD
Atomoxetine—Infection—Topiramate—obesity	1.31e-05	0.000384	CcSEcCtD
Atomoxetine—Rash—Bupropion—obesity	1.3e-05	0.000383	CcSEcCtD
Atomoxetine—Dermatitis—Bupropion—obesity	1.3e-05	0.000382	CcSEcCtD
Atomoxetine—Shock—Topiramate—obesity	1.29e-05	0.000381	CcSEcCtD
Atomoxetine—Headache—Bupropion—obesity	1.29e-05	0.00038	CcSEcCtD
Atomoxetine—Nervous system disorder—Topiramate—obesity	1.29e-05	0.000379	CcSEcCtD
Atomoxetine—Tachycardia—Topiramate—obesity	1.28e-05	0.000378	CcSEcCtD
Atomoxetine—Skin disorder—Topiramate—obesity	1.28e-05	0.000376	CcSEcCtD
Atomoxetine—Hyperhidrosis—Topiramate—obesity	1.27e-05	0.000374	CcSEcCtD
Atomoxetine—Fluoxetine—HTR2A—obesity	1.26e-05	0.0155	CrCbGaD
Atomoxetine—Anorexia—Topiramate—obesity	1.25e-05	0.000369	CcSEcCtD
Atomoxetine—Nausea—Bupropion—obesity	1.23e-05	0.000361	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Topiramate—obesity	1.2e-05	0.000352	CcSEcCtD
Atomoxetine—Insomnia—Topiramate—obesity	1.19e-05	0.00035	CcSEcCtD
Atomoxetine—Paraesthesia—Topiramate—obesity	1.18e-05	0.000347	CcSEcCtD
Atomoxetine—Maprotiline—HTR2A—obesity	1.18e-05	0.0145	CrCbGaD
Atomoxetine—Somnolence—Topiramate—obesity	1.17e-05	0.000344	CcSEcCtD
Atomoxetine—Dyspepsia—Topiramate—obesity	1.16e-05	0.00034	CcSEcCtD
Atomoxetine—Fenoprofen—PTGS2—obesity	1.15e-05	0.0142	CrCbGaD
Atomoxetine—Decreased appetite—Topiramate—obesity	1.14e-05	0.000336	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Topiramate—obesity	1.14e-05	0.000334	CcSEcCtD
Atomoxetine—Fatigue—Topiramate—obesity	1.13e-05	0.000333	CcSEcCtD
Atomoxetine—Constipation—Topiramate—obesity	1.12e-05	0.000331	CcSEcCtD
Atomoxetine—Pain—Topiramate—obesity	1.12e-05	0.000331	CcSEcCtD
Atomoxetine—Phenoxybenzamine—ADRB2—obesity	1.12e-05	0.0138	CrCbGaD
Atomoxetine—Nortriptyline—HTR2C—obesity	1.11e-05	0.0137	CrCbGaD
Atomoxetine—Propranolol—ADRB2—obesity	1.1e-05	0.0136	CrCbGaD
Atomoxetine—Feeling abnormal—Topiramate—obesity	1.08e-05	0.000319	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Topiramate—obesity	1.08e-05	0.000316	CcSEcCtD
Atomoxetine—Methadone—CYP19A1—obesity	1.05e-05	0.013	CrCbGaD
Atomoxetine—Urticaria—Topiramate—obesity	1.05e-05	0.000307	CcSEcCtD
Atomoxetine—Abdominal pain—Topiramate—obesity	1.04e-05	0.000306	CcSEcCtD
Atomoxetine—Body temperature increased—Topiramate—obesity	1.04e-05	0.000306	CcSEcCtD
Atomoxetine—Fenoprofen—ALB—obesity	1.03e-05	0.0127	CrCbGaD
Atomoxetine—Desipramine—ADRB1—obesity	9.92e-06	0.0122	CrCbGaD
Atomoxetine—Asthenia—Topiramate—obesity	9.44e-06	0.000278	CcSEcCtD
Atomoxetine—Pruritus—Topiramate—obesity	9.31e-06	0.000274	CcSEcCtD
Atomoxetine—Nortriptyline—SLC6A4—obesity	9.2e-06	0.0113	CrCbGaD
Atomoxetine—Nortriptyline—DRD2—obesity	9.15e-06	0.0113	CrCbGaD
Atomoxetine—Desipramine—HTR2C—obesity	9.14e-06	0.0113	CrCbGaD
Atomoxetine—Diarrhoea—Topiramate—obesity	9e-06	0.000265	CcSEcCtD
Atomoxetine—Phenprocoumon—ALB—obesity	8.86e-06	0.0109	CrCbGaD
Atomoxetine—Nortriptyline—CYP2E1—obesity	8.81e-06	0.0109	CrCbGaD
Atomoxetine—Dizziness—Topiramate—obesity	8.7e-06	0.000256	CcSEcCtD
Atomoxetine—Fluoxetine—ALB—obesity	8.62e-06	0.0106	CrCbGaD
Atomoxetine—Vomiting—Topiramate—obesity	8.36e-06	0.000246	CcSEcCtD
Atomoxetine—Desipramine—ADRB2—obesity	8.34e-06	0.0103	CrCbGaD
Atomoxetine—Rash—Topiramate—obesity	8.29e-06	0.000244	CcSEcCtD
Atomoxetine—Dermatitis—Topiramate—obesity	8.29e-06	0.000244	CcSEcCtD
Atomoxetine—Headache—Topiramate—obesity	8.24e-06	0.000242	CcSEcCtD
Atomoxetine—Warfarin—ALB—obesity	7.86e-06	0.00969	CrCbGaD
Atomoxetine—Nausea—Topiramate—obesity	7.81e-06	0.00023	CcSEcCtD
Atomoxetine—Orphenadrine—CYP2E1—obesity	7.7e-06	0.0095	CrCbGaD
Atomoxetine—Desipramine—SLC6A4—obesity	7.57e-06	0.00934	CrCbGaD
Atomoxetine—Desipramine—DRD2—obesity	7.53e-06	0.00929	CrCbGaD
Atomoxetine—Desipramine—CYP2E1—obesity	7.25e-06	0.00894	CrCbGaD
Atomoxetine—Nortriptyline—HTR2A—obesity	7.07e-06	0.00872	CrCbGaD
Atomoxetine—Ketoprofen—PTGS2—obesity	6.81e-06	0.00839	CrCbGaD
Atomoxetine—Ketoprofen—ALB—obesity	6.06e-06	0.00748	CrCbGaD
Atomoxetine—Desipramine—HTR2A—obesity	5.82e-06	0.00718	CrCbGaD
Atomoxetine—Nortriptyline—ALB—obesity	4.84e-06	0.00597	CrCbGaD
Atomoxetine—HTR2C—Signaling Pathways—APOE—obesity	5.61e-07	2.41e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RHOA—obesity	5.6e-07	2.4e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CAV1—obesity	5.56e-07	2.38e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LPA—obesity	5.56e-07	2.38e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NOS3—obesity	5.54e-07	2.38e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PIK3R1—obesity	5.54e-07	2.38e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—APOA1—obesity	5.54e-07	2.38e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CYP2E1—obesity	5.54e-07	2.38e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GGT1—obesity	5.53e-07	2.37e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT1—obesity	5.53e-07	2.37e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NQO1—obesity	5.48e-07	2.35e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NCOA1—obesity	5.44e-07	2.34e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LPIN1—obesity	5.44e-07	2.33e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—PIK3CA—obesity	5.43e-07	2.33e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—PIK3CA—obesity	5.39e-07	2.31e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—STK11—obesity	5.37e-07	2.3e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CYP19A1—obesity	5.37e-07	2.3e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ESR1—obesity	5.35e-07	2.3e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PRKCD—obesity	5.35e-07	2.3e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOA5—obesity	5.33e-07	2.29e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PRKCB—obesity	5.29e-07	2.27e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—F2—obesity	5.29e-07	2.27e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—PIK3CA—obesity	5.28e-07	2.27e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MTOR—obesity	5.27e-07	2.26e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PIK3CB—obesity	5.27e-07	2.26e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GCG—obesity	5.25e-07	2.25e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—SLC2A4—obesity	5.25e-07	2.25e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—C3—obesity	5.23e-07	2.24e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PIK3CB—obesity	5.23e-07	2.24e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MTOR—obesity	5.23e-07	2.24e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—BAD—obesity	5.23e-07	2.24e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CYCS—obesity	5.18e-07	2.22e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MTOR—obesity	5.12e-07	2.2e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PIK3CB—obesity	5.12e-07	2.2e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GGT1—obesity	5.08e-07	2.18e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT1—obesity	5.08e-07	2.18e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CLOCK—obesity	5.08e-07	2.18e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SLC22A1—obesity	5.08e-07	2.18e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PIK3CG—obesity	5.06e-07	2.17e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NCOA1—obesity	5.01e-07	2.15e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IRS1—obesity	5e-07	2.15e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—COMT—obesity	4.99e-07	2.14e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IRS2—obesity	4.98e-07	2.14e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AGT—obesity	4.97e-07	2.13e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SULT2A1—obesity	4.95e-07	2.12e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GLP1R—obesity	4.95e-07	2.12e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CYP19A1—obesity	4.94e-07	2.12e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—STK11—obesity	4.94e-07	2.12e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARGC1A—obesity	4.92e-07	2.11e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GNB3—obesity	4.92e-07	2.11e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—HMOX1—obesity	4.9e-07	2.1e-05	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—AKT1—obesity	4.89e-07	2.1e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—DPYD—obesity	4.87e-07	2.09e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LEP—obesity	4.87e-07	2.09e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—APOE—obesity	4.87e-07	2.09e-05	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—AKT1—obesity	4.85e-07	2.08e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CAV1—obesity	4.83e-07	2.07e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—POMC—obesity	4.82e-07	2.07e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—APOA1—obesity	4.81e-07	2.07e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—obesity	4.81e-07	2.07e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—INS—obesity	4.79e-07	2.06e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GNAS—obesity	4.79e-07	2.06e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—obesity	4.78e-07	2.05e-05	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—AKT1—obesity	4.75e-07	2.04e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL2—obesity	4.71e-07	2.02e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOB—obesity	4.69e-07	2.01e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PRKAR2B—obesity	4.69e-07	2.01e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—obesity	4.68e-07	2.01e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—DCN—obesity	4.66e-07	2e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ESR1—obesity	4.65e-07	2e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IGF1—obesity	4.63e-07	1.99e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—AKT2—obesity	4.63e-07	1.99e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PRKCB—obesity	4.59e-07	1.97e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—F2—obesity	4.59e-07	1.97e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—COMT—obesity	4.59e-07	1.97e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP9—obesity	4.58e-07	1.96e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP9—obesity	4.54e-07	1.95e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—BAD—obesity	4.54e-07	1.95e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CPT1A—obesity	4.53e-07	1.94e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GNB3—obesity	4.52e-07	1.94e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARGC1A—obesity	4.52e-07	1.94e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—HMOX1—obesity	4.5e-07	1.93e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—LPL—obesity	4.48e-07	1.92e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MAPK8—obesity	4.45e-07	1.91e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PIK3CD—obesity	4.45e-07	1.91e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP9—obesity	4.45e-07	1.91e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NAMPT—obesity	4.44e-07	1.91e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—AKT1—obesity	4.44e-07	1.91e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MAPK8—obesity	4.42e-07	1.9e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LIPC—obesity	4.41e-07	1.89e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GCK—obesity	4.41e-07	1.89e-05	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—PIK3CA—obesity	4.41e-07	1.89e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—AKT1—obesity	4.41e-07	1.89e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GNAS—obesity	4.41e-07	1.89e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SERPINE1—obesity	4.4e-07	1.89e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PIK3CG—obesity	4.4e-07	1.89e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOC3—obesity	4.39e-07	1.88e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GPX1—obesity	4.37e-07	1.88e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IRS1—obesity	4.34e-07	1.86e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MAPK8—obesity	4.33e-07	1.86e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—AKT1—obesity	4.31e-07	1.85e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOB—obesity	4.31e-07	1.85e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TYK2—obesity	4.28e-07	1.84e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CETP—obesity	4.26e-07	1.83e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CD36—obesity	4.26e-07	1.83e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RHOA—obesity	4.25e-07	1.82e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SDC1—obesity	4.21e-07	1.81e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PIK3R1—obesity	4.2e-07	1.8e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NOS3—obesity	4.2e-07	1.8e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—POMC—obesity	4.18e-07	1.8e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—INS—obesity	4.16e-07	1.79e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—AKR1C3—obesity	4.14e-07	1.78e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—LPL—obesity	4.12e-07	1.77e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL2—obesity	4.09e-07	1.76e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SCARB1—obesity	4.08e-07	1.75e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—STAT3—obesity	4.07e-07	1.75e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—STAT3—obesity	4.04e-07	1.73e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MTHFR—obesity	4.03e-07	1.73e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IGF1—obesity	4.02e-07	1.73e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AKT2—obesity	4.02e-07	1.73e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GPX1—obesity	4.02e-07	1.72e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—PIK3CA—obesity	4e-07	1.72e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SREBF1—obesity	3.96e-07	1.7e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARA—obesity	3.96e-07	1.7e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—STAT3—obesity	3.95e-07	1.7e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CD36—obesity	3.91e-07	1.68e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PIK3CB—obesity	3.88e-07	1.66e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MTOR—obesity	3.88e-07	1.66e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PIK3CD—obesity	3.86e-07	1.66e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT2—obesity	3.85e-07	1.65e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—AGT—obesity	3.83e-07	1.64e-05	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—PIK3CA—obesity	3.83e-07	1.64e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SERPINE1—obesity	3.82e-07	1.64e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MYC—obesity	3.78e-07	1.62e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—obesity	3.77e-07	1.62e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—FASN—obesity	3.77e-07	1.62e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOE—obesity	3.75e-07	1.61e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MYC—obesity	3.75e-07	1.61e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—BCHE—obesity	3.75e-07	1.61e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—obesity	3.74e-07	1.61e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CAV1—obesity	3.72e-07	1.6e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TYK2—obesity	3.72e-07	1.6e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—APOA1—obesity	3.71e-07	1.59e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MTHFR—obesity	3.71e-07	1.59e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RHOA—obesity	3.69e-07	1.58e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MYC—obesity	3.67e-07	1.58e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—obesity	3.67e-07	1.57e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NOS3—obesity	3.65e-07	1.57e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PIK3R1—obesity	3.65e-07	1.57e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARA—obesity	3.64e-07	1.56e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYP2E1—obesity	3.62e-07	1.55e-05	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—AKT1—obesity	3.6e-07	1.54e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NQO1—obesity	3.58e-07	1.54e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.55e-07	1.52e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—obesity	3.54e-07	1.52e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—AGT—obesity	3.52e-07	1.51e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—PIK3CA—obesity	3.48e-07	1.49e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOE—obesity	3.45e-07	1.48e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—SLC2A4—obesity	3.43e-07	1.47e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GCG—obesity	3.43e-07	1.47e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CAV1—obesity	3.42e-07	1.47e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—APOA1—obesity	3.41e-07	1.46e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PIK3CG—obesity	3.39e-07	1.45e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYCS—obesity	3.39e-07	1.45e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP9—obesity	3.37e-07	1.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PIK3CB—obesity	3.37e-07	1.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MTOR—obesity	3.37e-07	1.45e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GGT1—obesity	3.32e-07	1.43e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT1—obesity	3.32e-07	1.43e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MAPK8—obesity	3.28e-07	1.41e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NCOA1—obesity	3.27e-07	1.41e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARG—obesity	3.27e-07	1.4e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—AKT1—obesity	3.27e-07	1.4e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—STK11—obesity	3.23e-07	1.38e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYP19A1—obesity	3.23e-07	1.38e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—POMC—obesity	3.22e-07	1.38e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PIK3CA—obesity	3.21e-07	1.38e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—INS—obesity	3.21e-07	1.38e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PIK3CA—obesity	3.19e-07	1.37e-05	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—AKT1—obesity	3.13e-07	1.34e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PIK3CA—obesity	3.12e-07	1.34e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PIK3CG—obesity	3.12e-07	1.34e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—obesity	3.08e-07	1.32e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARG—obesity	3.01e-07	1.29e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—COMT—obesity	3e-07	1.29e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—STAT3—obesity	3e-07	1.29e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PIK3CD—obesity	2.98e-07	1.28e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—POMC—obesity	2.97e-07	1.27e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARGC1A—obesity	2.96e-07	1.27e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GNB3—obesity	2.96e-07	1.27e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—INS—obesity	2.95e-07	1.27e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—HMOX1—obesity	2.94e-07	1.26e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—obesity	2.94e-07	1.26e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP9—obesity	2.93e-07	1.26e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GNAS—obesity	2.88e-07	1.24e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MAPK8—obesity	2.85e-07	1.22e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—obesity	2.84e-07	1.22e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—AKT1—obesity	2.84e-07	1.22e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—obesity	2.82e-07	1.21e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOB—obesity	2.82e-07	1.21e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PIK3R1—obesity	2.81e-07	1.21e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NOS3—obesity	2.81e-07	1.21e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MYC—obesity	2.78e-07	1.2e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—obesity	2.78e-07	1.19e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—obesity	2.76e-07	1.19e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PIK3CD—obesity	2.74e-07	1.18e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—obesity	2.7e-07	1.16e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LPL—obesity	2.69e-07	1.16e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GPX1—obesity	2.63e-07	1.13e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—AKT1—obesity	2.62e-07	1.13e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—AKT1—obesity	2.6e-07	1.12e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—STAT3—obesity	2.6e-07	1.12e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PIK3CB—obesity	2.6e-07	1.11e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PIK3R1—obesity	2.59e-07	1.11e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NOS3—obesity	2.59e-07	1.11e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS2—obesity	2.57e-07	1.1e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CD36—obesity	2.56e-07	1.1e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—AKT1—obesity	2.55e-07	1.09e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MTHFR—obesity	2.42e-07	1.04e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MYC—obesity	2.42e-07	1.04e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—obesity	2.41e-07	1.04e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PIK3CB—obesity	2.39e-07	1.02e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARA—obesity	2.38e-07	1.02e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS2—obesity	2.37e-07	1.02e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PIK3CA—obesity	2.36e-07	1.01e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—AGT—obesity	2.3e-07	9.89e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOE—obesity	2.26e-07	9.69e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CAV1—obesity	2.24e-07	9.6e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—APOA1—obesity	2.23e-07	9.58e-06	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—obesity	2.09e-07	8.98e-06	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PIK3CA—obesity	2.05e-07	8.81e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PIK3CG—obesity	2.04e-07	8.74e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARG—obesity	1.97e-07	8.44e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—POMC—obesity	1.94e-07	8.32e-06	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—AKT1—obesity	1.93e-07	8.29e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—INS—obesity	1.93e-07	8.28e-06	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—obesity	1.82e-07	7.8e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PIK3CD—obesity	1.79e-07	7.69e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—obesity	1.77e-07	7.59e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PIK3R1—obesity	1.69e-07	7.26e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NOS3—obesity	1.69e-07	7.26e-06	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AKT1—obesity	1.68e-07	7.2e-06	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PIK3CA—obesity	1.58e-07	6.79e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PIK3CB—obesity	1.56e-07	6.7e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS2—obesity	1.55e-07	6.64e-06	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PIK3CA—obesity	1.46e-07	6.25e-06	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—AKT1—obesity	1.29e-07	5.55e-06	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—AKT1—obesity	1.19e-07	5.1e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PIK3CA—obesity	9.52e-08	4.08e-06	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—AKT1—obesity	7.77e-08	3.34e-06	CbGpPWpGaD
